Skip to main content
SpringerLink
Log in

Issues in CPPD Nomenclature and Classification

  • Crystal Arthritis (L Stamp, Section Editor)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This paper covers confusion and challenges in the nomenclature of calcium pyrophosphate deposition disease. Clinicians, investigators, and patients are faced with a variety of terms that are used to describe CPPD and its phenotypes, and clarity is greatly needed to help advance research and patient care. Motivation for the upcoming development of CPPD classification criteria is reviewed.

Recent Findings

EULAR proposed recommended terminology for CPPD in 2011. International Classification of Diseases (ICD-9 and ICD-10) billing codes identify definite or probable CPPD with variable accuracy depending on the clinical setting and comparator group. READ diagnostic codes have been employed to identify pseudogout in UK datasets but their accuracy has not been evaluated. CPPD classification criteria will provide a system for identifying a relatively homogenous group of patients to be included in clinical studies, enabling comparison of outcomes across studies.

Summary

CPPD nomenclature remains challenging for clinicians, investigators, and patients. A lay-friendly definition of CPPD, using easily accessible terminology, would be welcome. CPPD classification criteria are a necessary step in moving forward CPPD clinical research and may involve a range of clinical, laboratory, and imaging modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Abhishek A, Neogi T, Choi H, Doherty M, Rosenthal AK, Terkeltaub R. Review: unmet needs and the path forward in joint disease associated with calcium pyrophosphate crystal deposition. Arthritis & rheumatology. 2018;70:1182–91 This review highlights challenges to advancing the research agenda in CPPD, including the lack of classification criteria.

    Article  Google Scholar 

  2. McCarty DJ, Kohn NN, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”: I. clinical aspects. Ann Intern Med. 1962;56:711–37.

    Article  CAS  Google Scholar 

  3. Kohn NN, Hughes RE, McCarty DJ, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”. Ann Intern Med. 1962;56:738–45.

    Article  CAS  Google Scholar 

  4. Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374:2575–84.

    Article  CAS  Google Scholar 

  5. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563–70.

    Article  CAS  Google Scholar 

  6. Ryan L, McCarty D. Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis. In: McCarty D, editor. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger; 1985. p. 1515–46.

    Google Scholar 

  7. McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria. Ann Intern Med. 1977;87:241–2.

    Article  CAS  Google Scholar 

  8. Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, et al. Gout, hyperuricemia, and crystal-associated disease network consensus statement regarding labels and definitions for disease elements in gout. Arthritis care & research. 2019;71:427–34.

    Article  Google Scholar 

  9. van der Heijde D, Daikh DI, Betteridge N, et al. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers, and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Arthritis & rheumatology. 2018;70:826–31.

    Article  Google Scholar 

  10. Tanikawa H, Ogawa R, Okuma K, Harato K, Niki Y, Kobayashi S, et al. Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography. J Orthop Surg Res. 2018;13:73.

    Article  Google Scholar 

  11. Utsinger PD, Resnick D, Zvaifler NJ. Wrist arthropathy in calcium pyrophosphate dihydrate deposition disease. Arthritis Rheum. 1975;18:485–91.

    Article  CAS  Google Scholar 

  12. Lee KA, Lee SH, Kim HR. Diagnostic value of ultrasound in calcium pyrophosphate deposition disease of the knee joint. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2019;27:781–787.

  13. Barskova VG, Kudaeva FM, Bozhieva LA, Smirnov AV, Volkov AV, Nasonov EL. Comparison of three imaging techniques in diagnosis of chondrocalcinosis of the knees in calcium pyrophosphate deposition disease. Rheumatology. 2013;52:1090–4.

    Article  Google Scholar 

  14. Filippou G, Adinolfi A, Iagnocco A, Filippucci E, Cimmino MA, Bertoldi I, et al. Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2016;24:973–81.

    Article  CAS  Google Scholar 

  15. Gamon E, Combe B, Barnetche T, Mouterde G. Diagnostic value of ultrasound in calcium pyrophosphate deposition disease: a systematic review and meta-analysis. RMD Open. 2015;1:e000118.

    Article  Google Scholar 

  16. Pascart T, Norberciak L, Legrand J, Becce F, Budzik JF. Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2019.

  17. Stamp LK, Anderson NG, Becce F, Rajeswari M, Polson M, Guyen O, et al. Clinical utility of multi-energy spectral photon-counting computed tomography in crystal arthritis. Arthritis & rheumatology. 2019.

  18. O’Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40:1620–39.

    Article  Google Scholar 

  19. Nigwekar SU, Solid CA, Ankers E, et al. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014;29(Suppl 3):S724–31.

    Article  Google Scholar 

  20. •• Bartels CM, Singh JA, Parperis K, Huber K, Rosenthal AK. Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2015;21:189–92 This is the first administrative claims–based algorithm for CPPD.

    Article  Google Scholar 

  21. Kleiber Balderrama C, Rosenthal AK, Lans D, Singh JA, Bartels CM. Calcium pyrophosphate deposition disease and associated medical comorbidities: a National Cross-Sectional Study of US veterans. Arthritis Care & Research. 2017;69:1400–6.

    Article  CAS  Google Scholar 

  22. Tedeschi SK, Solomon DH, Liao KP. Pseudogout among patients fulfilling a billing code algorithm for calcium pyrophosphate deposition disease. Rheumatol Int. 2018;38:1083–8.

    Article  CAS  Google Scholar 

  23. Rho YH, Zhu Y, Zhang Y, Reginato AM, Choi HK. Risk factors for pseudogout in the general population. Rheumatology. 2012;51:2070–4.

    Article  Google Scholar 

  24. Roddy E, Muller S, Paskins Z, Hider SL, Blagojevic-Bucknall M, Mallen CD. Incident acute pseudogout and prior bisphosphonate use: matched case-control study in the UK. Clinical Practice Research Datalink Medicine (Baltimore). 2017;96:e6177.

    Article  CAS  Google Scholar 

  25. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the general practice research database: a systematic review. Br J Clin Pharmacol. 2010;69:4–14.

    Article  CAS  Google Scholar 

  26. Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Distinctions between diagnostic and classification criteria? Arthritis care & Research. 2015;67:891–7.

    Article  Google Scholar 

  27. Neogi T, Jansen TL, Dalbeth N, et al. Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & rheumatology. 2015;2015(67):2557–68.

    Article  Google Scholar 

  28. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism. 2010;2010(62):2569–81.

    Article  Google Scholar 

  29. Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, et al. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:634–40.

    Article  Google Scholar 

  30. Singh G, Lingala B, Mithal A. Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology. 2019.

  31. Vargas-Santos AB, Taylor WJ, Neogi T. Gout classification criteria: update and Implications. Curr Rheumatol Rep. 2016;18:46.

    Article  Google Scholar 

  32. • Berendsen D, Neogi T, Taylor WJ, Dalbeth N, Jansen TL. Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training. Clinical Rheumatology. 2017;36:641–7 This study identified that CPP crystals were less accurately identified than monosodium urate crystals via images from polarized light microscopy.

    Article  CAS  Google Scholar 

  33. Swan A, Amer H, Dieppe P. The value of synovial fluid assays in the diagnosis of joint disease: a literature survey. Ann Rheum Dis. 2002;61:493–8.

    Article  CAS  Google Scholar 

  34. Andres M, Vela P, Jovani V, Pascual E. Most needle-shaped calcium pyrophosphate crystals lack birefringence. Rheumatology. 2019;58:1095–8.

    Article  Google Scholar 

  35. Zell M, Zhang D, FitzGerald J. Diagnostic advances in synovial fluid analysis and radiographic identification for crystalline arthritis. Curr Opin Rheumatol. 2019;31:134–43.

    Article  CAS  Google Scholar 

  36. McCarthy GM, Dunne A. Calcium crystal deposition diseases - beyond gout. Nat Rev Rheumatol. 2018;14:592–602.

    Article  CAS  Google Scholar 

  37. •• Filippou G, Scire CA, Damjanov N, et al. Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force. J Rheumatol. 2017;44:1744–9 This manuscript presents the OMERACT ultrasound definitions for CPPD in the fibrocartilage, hyaline cartilage, tendon, and synovial fluid.

    Article  Google Scholar 

  38. Filippou G, Scire CA, Adinolfi A, et al. Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. Ann Rheum Dis. 2018;77:1194–9.

    Article  Google Scholar 

  39. Misra D, Guermazi A, Sieren JP, Lynch J, Torner J, Neogi T, et al. CT imaging for evaluation of calcium crystal deposition in the knee: initial experience from the Multicenter Osteoarthritis (MOST) study. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2015;23:244–8.

    Article  CAS  Google Scholar 

  40. Diekhoff T, Kiefer T, Stroux A, Pilhofer I, Juran R, Mews J, et al. Detection and characterization of crystal suspensions using single-source dual-energy computed tomography: a phantom model of crystal arthropathies. Investig Radiol. 2015;50:255–60.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, 60 Fenwood Road, Boston, MA, 02115, USA

    Sara K. Tedeschi

Authors
  1. Sara K. Tedeschi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara K. Tedeschi.

Ethics declarations

Conflict of Interest

Sara K. Tedeschi is a member of the ACR/EULAR CPPD Classification Criteria team.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Crystal Arthritis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tedeschi, S.K. Issues in CPPD Nomenclature and Classification. Curr Rheumatol Rep 21, 49 (2019). https://doi.org/10.1007/s11926-019-0847-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-019-0847-4

Keywords

Search

Navigation